In this study, an examination of p-Akt (Serine 473) showed that treatment with compounds 1 and 2 after viral infection decreased p-Akt levels compared with viral-infected/untreated cells (Figure 2A,B). This evidence concerns the gene AKT1 and viral infectious disease.